Vaccine-modified NF-kB and GR signaling in cervicovaginal epithelium correlates with protection
Mucosal Immunology Aug 19, 2017
Shang L, et al. – In order to figure out whether vaccine–modified NF–kB and glucocorticoid receptor (GR) signaling in cervicovaginal epithelium correlated with protection, experts conducted this study. In this study, targeting the balance of NF–kB and GR signaling in early cervicovaginal epithelium responses could moderate mucosal inflammation and target cell availability after vaginal infection. In this way, it offered a complementary approach to current prevention strategies.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries